Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Recruitment-status index

CompletedPeptide Trials.

Explore every peptide study grouped under completed in the local registry snapshot. Check the source record before relying on recruitment status, because registry entries can change.

Studies
1,341
Recruiting
0
Completed
1,341
Results posted
468
Countries
87
Avg enrollment
371

Velocity

Completed trials by start year

Study start year · indexed snapshot

90684523019971997: 1 trials1998: 0 trials1999: 2 trials2000: 5 trials2001: 16 trials20022002: 16 trials2003: 22 trials2004: 24 trials2005: 31 trials2006: 52 trials20072007: 35 trials2008: 45 trials2009: 49 trials2010: 45 trials2011: 45 trials20122012: 55 trials2013: 51 trials2014: 54 trials2015: 55 trials2016: 65 trials20172017: 79 trials2018: 90 trials2019: 86 trials2020: 57 trials2021: 70 trials20222022: 77 trials2023: 81 trials2024: 88 trials2025: 39 trials20262026: 6 trials

Development

Trials by phase

Early Phase 113
Phase 1254
Phase 2350
Phase 3322
Phase 4169

Industry

Leading sponsors

Eli Lilly49
Novo Nordisk49
Sanofi46
Ipsen31
GlaxoSmithKline30
Shire30
AstraZeneca28
Novartis28

Therapeutic areas

Condition groups

Weight loss169
Type 2 diabetes119
Brain health31
Inflammation23
Pain21
Longevity12
Crohn's3

Compound leaders

Most represented peptides.

01Lixisenatide5802Pasireotide5003Ganirelix4704Enfuvirtide4405Pramlintide4406Lanreotide4307Carbetocin4208Teriparatide4209Dulaglutide4110Linaclotide4111Desmopressin3912Teduglutide39

Study explorer

Search this collection.

1,341 matching studies